VivaNeo

VivaNeo fertility clinic are the largest network of reproductive medicine facilities in Europe and currently consist of ten centres in Germany, the Netherlands, Denmark and Austria. Alongside the centres, the network also includes the VivaNeo Sperm Bank and VivaNeo Laboratory Diagnostics in Düsseldorf, Germany. The company currently has around 350 employees, including 50 doctors. In addition to all conventional reproductive medicine methods, VivaNeo also offers polar body diagnostics as an exclusive method of systematically determining viable oocytes with a chance of pregnancy. In 2011 the company was acquired by the Waterland Investment Group.
Company development
The VivaNeo Group was founded in 2011 by the physicians Martin Schorsch and Thomas Hahn, managers of the then largest independent reproductive medicine centre in Germany, the Wiesbaden Fertility Centre. That same year, the Fertility Clinic Dr. Sydow in Berlin joined the group.
In 2012 the group was expanded further, first with the addition of another large centre, the interdisciplinary Düsseldorf Fertility Centre, run by the physicians Michael Scholtes, Kersten Marx and Stefan Kissler. At the same time, they made the VivaNeo Sperm Bank, then known as Reprogen, and VivaNeo Laboratory Diagnostics, formerly known as the Benrath Laboratory, part of the group. At the end of that same year, the group was further expanded with the addition of an international site. Thanks to Mr Crooij and the Medisch Centrum Kinderwens in Leiderdorp (the Netherlands), the group gained its first international fertility specialist.
In July 2015, the group expanded to Denmark with the addition of the Storkklinik in Copenhagen. In September of that year, the two Austrian centres run by Dr Leonhard Loimer in Vienna and Wels also joined the VivaNeo Group. The latest addition to the Group was that of Karsten Petersen and his Zentrum Ciconia (Ciconia Clinic) in Aarhus in 2016.
Treatment methods
Hormone treatment
Failure to achieve pregnancy is often the result of hormone-related problems during egg maturation and ovulation. Hormone treatment can increase the likelihood of pregnancy in women.
Insemination
Insemination is a procedure in which ovulation is triggered using a hormone treatment and the sperm is transferred to the uterine cavity using a catheter.
IVF (in vitro fertilisation)
During IVF, or fertilisation outside the body, the eggs are harvested after hormonal stimulation and then brought together with the sperm in a test tube. This results in “spontaneous fertilisation”, without any further intervention, and in the natural selection of the sperm. The embryos are then transferred to the uterus.
ICSI (intracytoplasmic sperm injection)
A microinjection is used to artificially inseminate the eggs. The sperm is injected directly into the cytoplasm of the egg in a laboratory. An ICSI is often used if previous IVF attempts have failed or if a man’s fertility is limited. The subsequent procedure is identical to that of IVF.
Embryo transfer
After the eggs are extracted, they are artificially inseminated in a laboratory by IVF or ICSI. During embryo transfer, the fertilised eggs are then transplanted into the woman’s uterus.
Blastocyst transfer
A blastocyst transfer involves transferring one or more embryos which are already at an advanced stage of development.
Cryopreservation
Cryopreservation involves freezing and storing cells and tissue in liquid nitrogen. Unfertilised eggs, sperm, ovarian tissue or fertilised eggs can be stored in their pronuclear stage at -196 ºC over a long period of time.
TESE/MESA
TESE/MESA involves extracting sperm from a man if sperm cell harvesting cannot be achieved naturally for medical reasons.
Social freezing
VivaNeo, together with Seracell egg bank, took on a pioneering role in the introduction of social freezing in Germany. Social freezing is the process of freezing eggs. For example, eggs can be extracted and frozen before a possible loss of fertility (e.g. during chemotherapy), and then used at a later date.
Sperm donation
Sperm donation is the process of insemination with the help of a third-party sperm donor. This treatment is often used if a man has a genetic disease or serious infection, for example. The sperm donation is thoroughly and carefully tested and then stored in a frozen state until it is used (cryopreservation).
Locations
Germany
* MVZ VivaNeo Praxisklinik Sydow Berlin GmbH
* MVZ VivaNeo Kinderwunschzentrum Düsseldorf GmbH
* MVZ VivaNeo Kinderwunschzentrum Wiesbaden GmbH
* MVZ VivaNeo Kinderwunschpraxis Frankfurt GmbH
Austria
* VivaNeo - Kinderwunschklinik Vienna
* VivaNeo - Kinderwunschklinik Wels
Netherlands
* VivaNeo - Kinderwunschzentrum
Denmark
* VivaNeo - Ciconia Aarhus Fertilitetsklinik
* VivaNeo - Stork IVF Klinik
* VivaNeo - Copenhagen Fertilitetsklinik
 
< Prev   Next >